Dr. Mark Kris discusses cancer progression, as defined by RECIST criteria, and the situations in which increased tumor size in NSCLC need not prompt a change in standard chemotherapy. Medscape Hematology-Oncology
A presentation at the Oncology Nursing Society suggests that APNs can advocate on behalf of their patients to ensure access to care and can become involved health policy. Medscape Medical News
The FDA has approved a new indication for a combination of the renin inhibitor aliskiren and the diuretic hydrochlorothiazide, allowing its use for the first-line treatment of hypertension. Medscape Medical News
The dipeptidyl peptidase IV inhibitor vildagliptin (Galvus) is effective monotherapy for treatment-naive elderly patients with type 2 diabetes, according to a report in the December issue of Diabetes Care. Reuters Health Information
The atypical antipsychotic sertindole may prove effective in some patients who fail treatment with other antipsychotics, according to a report in the March issue BMC Psychiatry. Reuters Health Information
